Expert: Mifepristone under safety review in U.S. 

The U.S. Food and Drug Administration is reviewing the safety and efficacy of mifepristone, a drug used widely in medical abortions. The review has raised concerns about potential new restrictions on access to abortion in the United States. 

Christopher Labos, MD, is an Associate at McGill’s Office for Science and Society. He can discuss the known evidence on mifepristone and the broader implications of the review. 

christopher.labos [at] mcgill.ca (English, French)